Crossmark

Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey

Crossref DOI link: https://doi.org/10.1007/s00415-018-9159-2

Published Online: 2018-12-15

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Montagnese, Federica

White, Molly

Klein, Anke

Stahl, Kristina

Wenninger, Stephan

Schoser, Benedikt http://orcid.org/0000-0002-2757-8131
License Information

Text and Data Mining valid from 2018-12-15
More Information

Article History

Received: 20 October 2018

Revised: 8 December 2018

Accepted: 12 December 2018

First Online: 15 December 2018

Compliance with ethical standards

:

: FM, MW, AK, KS, SW have no conflicts of interest. BS is a scientific advisor of Nexien BioPharma, Inc.

: This study followed the tenets of the Declaration of Helsinki. As this survey was a patient organization (MW, AK) driven survey, done anonymously and blinded, no formal IRB approval was submitted.